β¨ Medicines Classification
2 FEBRUARY 2006
NEW ZEALAND GAZETTE, No. 10
Prochlorperazine; in packs containing not more than
10 tablets for the treatment of nausea associated with
migraine
Promethazine; for oral use except when specified elsewhere
in the Schedule
Salicylic acid; in medicines containing more than 40%
Silver sulfadiazine; except for external use in packs
containing 50 grams or less
Sodium picosulfate; in preparations for bowel cleansing
prior to diagnostic, medical or surgical procedures
Stramonium; for oral use in liquid form; in solid dose form
in medicines containing more than 0.3 milligrams per
dose or more than 1.2 milligrams per recommended
daily dose
Thenyldiamine; for oral use in solid dose form or in liquid
form containing 10 milligrams or less of thenyldiamine
per 5 millilitres except when specified elsewhere in the
Schedule
Triamcinolone; for buccal use in medicines containing
0.1% or less of triamcinolone acetonide and in pack sizes
no greater than 5 grams
Trimeprazine; for oral use in solid dose form or in liquid
form containing 10 milligrams or less per 5 millilitres;
except when specified elsewhere in the Schedule
Triprolidine; for oral use except when specified elsewhere in
the Schedule
Schedule 3
Pharmacy-only Medicines
Acetylcysteine; for oral use in medicines containing more
than 1 gram per recommended daily dose
Aciclovir; for external use for the treatment of herpes
labialis except in medicines containing 5% or less and
in tubes containing 10 grams or less
Amethocaine; for external use in medicines containing
10% or less and more than 2%
Antazoline; for ophthalmic use
Atropa belladonna; for external use in medicines containing
0.03% of the alkaloids of belladonna; for oral use in
liquid form in medicines containing 0.03% or less and
0.3 milligrams or less per dose and not more than 1.2
milligrams per recommended daily dose of the alkaloids
of belladonna or in solid dose form in medicines
containing 0.3 milligrams or less per dose form and not
more than 1.2 milligrams per recommended daily dose
of the alkaloids of belladonna
Atropine; for oral use in liquid form in medicines containing
0.03% or less and 0.3 milligrams or less per dose and
not more than 1.2 milligrams per recommended daily
dose or in solid dose form in medicines containing 0.3
milligrams or less per dose form and not more than
1.2 milligrams per recommended daily dose; in
medicines containing atropine sulfate for the treatment
of organophosphorous poisoning either in packs of up
to 20 tablets containing 0.6 milligrams or less per tablet
or in injections in packs of 5 or less containing 0.6
milligrams per millilitre or less; except when used as an
antidote in a device designed for self-injection; except
when sold by licencees under the Toxic Substances
Regulations
Beclomethasone; in aqueous nasal sprays delivering up
to 50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine
Benzocaine; in mouthwashes containing 10% or less; for
external use in medicines other than mouthwashes
containing 10% or less and more than 2% except in
throat lozenges containing 30 milligrams or less per dose
form
Benzydamine; for external use
Bifonazole; for external use except in medicines for tinea
pedis only or in shampoos containing 1% or less
Brompheniramine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing brompheniramine in the bedtime dose and in
preparations for adults or children two years of age or
more
Budesonide; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine
Chlorpheniramine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is
a sympathomimetic decongestant or in a day/night pack
containing chlorpheniramine in the bedtime dose and in
preparations for adults or children two years of age or
more
Ciclopirox; for dermal use in medicines containing 2% or
less except in medicines for tinea pedis only
Cinchocaine; for external use in medicines containing 0.5%
or less
Datura spp; for oral use in liquid form in medicines
containing 0.03% or less and 0.3 milligrams or less per
dose and not more than 1.2 milligrams per recommended
daily dose of total solanaceous alkaloids or in solid dose
form in medicines containing 0.3 milligrams or less
per dose form and not more than 1.2 milligrams per
recommended daily dose of total solanaceous alkaloids
Dexchlorpheniramine; for oral use when combined with one
or more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing dexchlorpheniramine in the bedtime dose and
in preparations for adults or children two years of age or
more
Dextromethorphan; in liquid form containing more than
0.25% or in solid dose form containing more than 15
milligrams per dose form when in packs containing not
more than 600 milligrams and with a recommended daily
dose of not more than 120 milligrams
Dibrompropamidine; for ophthalmic use
Diclofenac; in solid dose form containing 12.5 milligrams or
less per dose form in packs of not more than 20 tablets
or capsules
Dimenhydrinate; for oral use in a sealed container of not
more than 10 tablets or capsules for the prevention or
treatment of motion sickness except when sold at a
transport terminal or aboard a ship or plane
Diphenhydramine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is
a sympathomimetic decongestant or in a day/night
pack containing diphenhydramine in the bedtime dose
and in preparations for adults or children two years of
age or more; in a sealed container of not more than
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 10
Gazette.govt.nz —
NZ Gazette 2006, No 10
β¨ LLM interpretation of page content
π₯
Classification of Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines